DocStore

The Premier Marketplace to Buy and Sell Professional Documents

DocStore Search:
Per Page: 152550
  • Computed Tomography Systems Market to 2019 - Lower Radiation Dose and Improved Workflow in Advanced CT Systems to Increase Adoption Rates
    Computed Tomography Systems Market to 2019 - Lower Radiation Dose and Improved Workflow in Advanced CT Systems to Increase Adoption Rates

    $3,500.00

    $3,500.00

    From:GBI Research

    Document Overview:
    GBI Research’s report, “Computed Tomography Systems Market to 2019 - Lower Radiation Dose and Improved Workflow in Advanced CT Systems to Increase Adoption Rates” looks at the market, competitive landscape, and trends for three computed tomography systems segments: high slice computed tomography systems, mid slice computed tomography systems and low slice computed tomography systems. The report provides comprehensive information on the key trends affecting these segments and analyzes the market dynamics. It also reviews the competitive landscape and the details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts. Scope - Key geographies of the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil - Information on market size for three computed tomography systems segments: high slice computed tomography systems, mid slice computed tomography systems and low slice computed tomography systems. - Annualized market revenue data forecast to 2019 and company share data for 2012 - Qualitative analysis of key trends in the computed tomography systems market - Information on the leading market players, the competitive landscape, and the leading technologies - Information on key players: GE Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation, Philips Healthcare, Hitachi Medical Corporation and Neusoft Medical Systems Co., Ltd. Reasons to buy - Develop business strategies by understanding the trends and developments driving the global computed tomography systems market - Design and enhance your product development, marketing, and sales strategies - Exploit M&A opportunities by identifying the market players with the most innovative pipelines - Develop market-entry and market-expansion strategies - Identify the key players best positioned to take advantage of eme
    View Document
  • Mammography Equipment Market to 2019 - Growth Driven by Technical Advances in Digital Radiography that Enhance Workflow and Improve Breast Cancer Detection
    Mammography Equipment Market to 2019 - Growth Driven by Technical Advances in Digital Radiography that Enhance Workflow and Improve Breast Cancer Detection

    $3,500.00

    $3,500.00

    From:GBI Research

    Document Overview:
    GBI Research’s report, “Mammography Equipment Market to 2019 - Growth Driven by Technical Advances in Digital Radiography that Enhance Workflow and Improve Breast Cancer Detection” looks at the market, competitive landscape, and trends for the two mammography equipment market segments: digital radiography mammography equipment and film-screen mammography equipment. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important Merger and Acquisition (M&A) deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope - Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil - Information on market size for the two mammography equipment market segments: full-field digital mammography equipment and film-screen mammography equipment - Annualized market revenue data forecast to 2019 and company share data for 2012 - Qualitative analysis of key trends in the mammography equipment market - Information on the competitive landscape, and the leading technologies of key players: Hologic, GE Healthcare, Siemens Healthcare, Philips Healthcare and FujiFilm Holdings Corporation - Information on reimbursement trends and market access for key countries Reasons to buy - Develop business strategies by understanding the trends and developments driving the global mammography equipment market - Design and enhance your product development, marketing, and sales strategies - Exploit M&A opportunities by identifying the market players with the most innovative pipelines - Develop market-entry and market-expansion strategies - Identify the key players best-positioned to take advantage of the emerging mark
    View Document
  • Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019
    Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019

    $3,500.00

    $3,500.00

    From:GBI Research

    Document Overview:
    GBI Research has released its latest report for the pharmaceuticals industry, “Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019”. There is currently a large number of blood glucose-lowering drugs in the crowded type 2 diabetes market indicated for the treatment of chronically high blood glucose. The market is led by Lantus, which achieved global sales amounting to $6.4 billion in 2012. Over the forecast period from 2012 to 2019, the safer, more efficacious newer classes of drug (GLP-1 agonists, DPP-4 Inhibitors and SGLT-2 inhibitors) are expected to capture substantial market shares, largely replacing older classes such as sulfonylureas and thiazolidinediones. Additionally, a variety of novel drugs belonging to these newer classes are due to enter the market, and are expected to offer a moderate improvement in terms of efficacy and safety. The price of these new therapies is expected to be high, but this is unlikely to hinder their uptake. As a result, as well as an overall increase in the prevalent population, GBI Research believes that the value of the global market has the potential to grow to reach $38.8 billion by 2019. Scope - A brief introduction to type 2 diabetes, including the symptoms, pathogenesis, risk factors and diagnosis - In-depth analysis of major glucose-lowering drugs for type 2 diabetes, including analyses of their safety, efficacy, treatment patterns, strengths/weaknesses and overall commercial prospects. Includes a heat map comparing major drugs in terms of safety, efficacy and dosing parameters. - Comprehensive review of the pipeline for type 2 diabetes therapies, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market in the forecast period. The pipeline is analyzed on the basis of phase distribution, molecule types and molecular targets. - Additional in-depth analysis of pipeline drug clinical
    View Document
  • Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth
    Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth

    $3,500.00

    $3,500.00

    From:GBI Research

    Document Overview:
    GBI Research, a leading business intelligence provider, has released its latest research report, “Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth”. The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16.6 billion in 2012 to a projected value of $21.6 billion in 2019. This growth is expected despite the generic erosion facing the leading brands, and is a consequence of new market entrants and a disease prevalence that continues to rise, albeit not at rates as high as have been seen in the past. Some new, costly asthma therapies could be set to enter the asthma market, including GlaxoSmithKline’s (GSK’s) recently approved Relvar (fluticasone/vilanterol), and multiple monoclonal antibodies (mAbs). These include reslizumab, mepolizumab and lebrikizumab, which are being developed by Teva, GSK and Roche respectively. The mAbs, in particular, have the potential to change the asthma treatment landscape, most notably with regards to severe forms of the disease. Although such therapy may only play the role of an alternative treatment in the asthma treatment algorithm, their ability to reduce exacerbation rates has strong clinical and commercial value. Scope The report assesses the current asthma market, and forecasts market trends to 2019, analyzing key drivers and barriers. The areas covered include the following - - A disease introduction, which defines the disease, including symptoms, diagnosis and treatment - Analysis of the landscape of the asthma market, including a comparison of the efficacy and safety of the most prominent brands - Detailed analysis of the asthma pipeline, including, among other parameters, details of drug distribution by phase, molecule type and mechanism of action. The asthma clinical trial landscape is then analyzed, with a particular emphasis on failure rates across phases as well as tren
    View Document
  • Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies
    Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies

    $3,500.00

    $3,500.00

    From:GBI Research

    Document Overview:
    GBI Research, the leading business intelligence provider, has released its latest research, “Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies”, which provides in-depth analysis of four key therapeutic indications within the Asia-Pacific (APAC) solid tumors market – bladder cancer, ovarian cancer, pancreatic cancer and prostate cancer – covering the four countries of Australia, China, India and Japan. The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these four solid tumor types. The value of the solid tumors market in the APAC region amounted to an estimated $1 billion in 2012 and is expected to register a modest Compound Annual Growth Rate (CAGR) of 12.3% to reach $2.3 billion in 2019. The key drivers for growth in this market include: new product approvals in ovarian, pancreatic and prostate cancers; expected launches from the promising ovarian and prostate cancer pipelines; and increased market penetration due to the anticipated implementation of social insurance in China. Conversely, the growth of the market in this region could face some restricting influences, including: the recent implementation of a price ceiling on essential drugs in India; anticipated pricing restrictions in China; low access and penetration; and price erosion due to generic competition. Scope The report analyzes treatment usage patterns, market characterization, pipeline analysis and key licensing and co-development deals in the bladder cancer, ovarian cancer, pancreatic cancer and prostate cancer in the four APAC markets of Australia, China, India and Japan. The report includes - - Disease overview, as well as treatment algorithms and treatment usage patterns - Market size and forecast
    View Document
  • Ostomy Drainage Bags Market to 2019 - Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential
    Ostomy Drainage Bags Market to 2019 - Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential

    $3,500.00

    $3,500.00

    From:GBI Research

    Document Overview:
    GBI Research’s report, “Ostomy Drainage Bags Market to 2019 - Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential” looks at the market, key market players, and market dynamics for the global ostomy drainage bags market. It provides a synopsis of the various factors influencing this market. The report also gives company descriptions and lists the key marketed products for major market players. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope - Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil - Information on market size for the three ostomy drainage bags market segments: colostomy, ileostomy and urostomy - Annualized market revenue data forecast to 2019 and company share data for 2012. - Information on the leading technologies of key players: Coloplast, Convatec, Hollister, B. Braun, Dansac and Alcare Reasons to buy - Develop business strategies by understanding the dynamics and developments driving the global ostomy drainage bags market - Design and enhance your product development, marketing, and sales strategies - Develop market-entry and market-expansion strategies - Identify the key players best positioned to take advantage of the emerging market opportunities - Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return - Identify, understand and capitalize on the next big thing in the ostomy drainage bags market landscape - Make more informed business decisions from insightful analysis of the global ostomy drainage bags market and the factors shaping it
    View Document
  • Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
    Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity

    $3,500.00

    $3,500.00

    From:GBI Research

    Document Overview:
    GBI Research, the leading business intelligence provider, has released its latest research, “Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity”. Obesity is often described as a global endemic, with incidence dramatically increasing over the past decades, particularly in developed countries. Being overweight or obese is a major risk factor in the development of many chronic diseases, including cardiovascular diseases, cancer, and diabetes, of which treatment incurs extensive economic and healthcare costs. Numerous anti-obesity drugs have been approved in the past decade, including Knoll Pharmaceutical’s Meridia (sibutramine) and Acomplia (rimonabant), only for them to be removed from the market due to evidence of suicidal thoughts, depression and cardiovascular problems with their long-term use. As such, healthcare professionals have a negative perception of such drugs and do not widely prescribe them, a major barrier to the growth of the anti-obesity therapeutics market. Only orlistat is currently deemed safe for the long-term treatment of obesity; being proven to produce a placebo-adjusted weight-loss average of a limited 3kg. Two anti-obesity drugs were approved in June and July 2012, and GBI Research believes that only one, Vivus’ Qsymia, has a strong enough safety and efficacy (average placebo-adjusted weight loss of 5kg at the medium dose) profile to make a significant impact on the market, providing it is proven safe in long-term-use studies. If proven safe, GBI Research expects the sales of Qsymia and other drugs expected to be approved over the forecast period to increase the market size to $2.7 billion. Although moderate, this is significantly below the market potential given the size of the prevalence population. Optimally safe and effective anti-obesity drugs which overcome healthcare professionals’ negative opinions will have to be developed if the size of the market is ever to reflect the prevalen
    View Document
  • Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth
    Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth

    $3,500.00

    $3,500.00

    From:GBI Research

    Document Overview:
    GBI Research, the leading business intelligence provider, has released its latest research, “Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth”. Currently there are a number of disease-modifying drugs in the Multiple Sclerosis (MS) market that are indicated for the treatment of relapsing forms of the disease, specifically reducing the frequency of disease relapses. The market is led by Copaxone, which achieved global sales of $4 billion in 2012. Over the forecast period 2012–2019, a variety of new drugs are due to enter the market that will offer a vast improvement in efficacy but also convenience, as many of these drugs are orally administered. Additionally, a high number of monoclonal Antibodies (mAbs) are due to enter the market and diversify it in terms of its portfolio for late stage or aggressive MS. All of these drugs have been shown to offer substantial improvements over current therapies. The price of these new therapies is expected to be high, particularly for the mAbs, but this is unlikely to hinder their uptake. As a result of this, as well as an overall increase in the treated population, GBI Research believes the global market has the potential to grow to a value of $17.9 billion by 2019. Scope - A brief introduction to MS, including the disease’s history, pathogenesis, risk factors and diagnosis. - In-depth analysis of the eight major disease-modifying drugs for MS, including analyses of their safety, efficacy, treatment patterns and strengths/weaknesses. Includes a heat map comparing the drugs in terms of safety and efficacy. - Comprehensive review of the pipeline for MS therapies, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market in the forecast period. The pipeline is analyzed on the basis of phase distribution, molecule types and molecular targets, as well as administration routes. - Additional a
    View Document
  • Purified Terephthalic Acid Global Market to 2020 - Overcapacity and Declining Margins to Hinder Global Demand in the Short Term
    Purified Terephthalic Acid Global Market to 2020 - Overcapacity and Declining Margins to Hinder Global Demand in the Short Term

    $3,500.00

    $3,500.00

    From:GBI Research

    Document Overview:
    GBI Research’s "Purified Terephthalic Acid Global Market to 2020 - Overcapacity and Declining Margins to Hinder Global Demand in the Short Term" is an in-depth report focusing on the demand side of the global Purified Terephthalic Acid (PTA) industry. The report provides the reader with detailed analysis and forecasts of the major economic and market trends expected to affect global PTA demand in all major regions of the world. It also provides analysis and description of the major drivers and restraints affecting PTA demand in various regions. Global PTA demand is assessed in terms of end-user segments, price, and competitive landscape, at both the regional and national level. Scope - Drivers, restraints and challenges affecting the growth of the PTA market for all the major regions: Asia-Pacific, Europe, North America, the Middle East and Africa, and South and Central America - Demand and production volume forecasts for the PTA markets of all major countries in the respective regions worldwide - Demand volume forecasts for the major end-user applications, highlighting trends and volume share analysis for each of these applications in all major countries - Pricing forecasts and analysis for the major countries and regions - PTA import and export trends in all the major countries - Competitive landscape for the PTA market, for major regions and major countries Reasons to buy - An understanding of regional PTA market dynamics, through detailed demand and production forecasts, end-use data and competitive landscape analysis - Detailed analysis at a country level, enabling the buyer to evaluate opportunities in emerging markets and quantify potential returns on investment - A detailed understanding of the factors that are expected to affect the growth of the PTA market in different regions of the world - An identification of the most attractive geographical locations, product segments and end-user applications, in order to increase business revenue
    View Document
  • Compression Therapy Market to 2019 - Growth due to Increased Awareness in Venous Disease Management Offset by Reimbursement Issues
    Compression Therapy Market to 2019 - Growth due to Increased Awareness in Venous Disease Management Offset by Reimbursement Issues

    $3,500.00

    $3,500.00

    From:GBI Research

    Document Overview:
    GBI Research’s report, “Compression Therapy Market to 2019 - Growth due to Increased Awareness in Venous Disease Management Offset by Reimbursement Issues” looks at the market, competitive landscape, and trends for the two compression therapy market segments: static compression therapy and dynamic compression therapy. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope - Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil - Information on market size for the two compression therapy market segments: static compression therapy and dynamic compression therapy. - Annualized market revenue data forecast to 2019 and company share data for 2011 - Qualitative analysis of key trends in the compression therapy market - Information on the competitive landscape, and the leading technologies of key players: Sigvaris, BSN Medical, medi GmbH & Co. KG, Covidien, Paul Hartmann, Laboratories Innothera, Julius Zorn, Arjohuntleigh, Thuasne and Smith & Nephew. - Information on reimbursement trends and market access for key countries Reasons to buy - Develop business strategies by understanding the trends and developments driving the global compression therapy market - Design and enhance your product development, marketing, and sales strategies - Exploit M&A opportunities by identifying the market players with the most innovative pipelines - Develop market-entry and market-expansion strategies - Identify the key players best positioned to take advantage of the emerging market opportunities - Exploit in-licensing and ou
    View Document
  • Cataract Surgery Devices Market to 2019 - Advanced Intraocular Lenses (IOLs) and a Growing Patient Population in Emerging Countries Offer Significant Growth Potential
    Cataract Surgery Devices Market to 2019 - Advanced Intraocular Lenses (IOLs) and a Growing Patient Population in Emerging Countries Offer Significant Growth Potential

    $3,500.00

    $3,500.00

    From:GBI Research

    Document Overview:
    GBI Research’s report, “Cataract Surgery Devices Market to 2019 - Advanced Intraocular Lenses (IOLs) and a Growing Patient Population in Emerging Countries Offer Significant Growth Potential" looks at the market, competitive landscape, and trends for the three cataract surgery devices market segments: intraocular lens (IOL), ophthalmic viscoelastic devices (OVD) and phacoemulsification equipment. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope - Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil - Information on market size for the five cataract surgery devices market segments: mechanical stapling devices, hemostats, tissue sealants, ligating clips and wound closure strips - Annualized market revenue data forecast to 2019 and company share data for 2011 - Qualitative analysis of key trends in the cataract surgery devices market - Information on the competitive landscape, and the leading technologies of key players: Alcon, Abbott Medical Optics, Bausch & Lomb, Hoya Corporation, Carl Zeiss Meditec & Aurolab. - Information on reimbursement trends and market access for key countries Reasons to buy - Develop business strategies by understanding the trends and developments driving the global cataract surgery devices market - Design and enhance your product development, marketing, and sales strategies - Exploit M&A opportunities by identifying the market players with the most innovative pipelines - Develop market-entry and market-expansion strategies - Identify the key players best positioned to take
    View Document
  • Wound Closure Devices Market to 2019 - New Product Launches and Favorable Clinical Outcomes for Tissue Sealants and Hemostats Drive Physician Adoption
    Wound Closure Devices Market to 2019 - New Product Launches and Favorable Clinical Outcomes for Tissue Sealants and Hemostats Drive Physician Adoption

    $3,500.00

    $3,500.00

    From:GBI Research

    Document Overview:
    GBI Research’s report, “Wound Closure Devices Market to 2019 - New Product Launches and Favorable Clinical Outcomes for Tissue Sealants and Hemostats Drive Physician Adoption” looks at the market, competitive landscape, and trends for the five wound closure devices market segments: mechanical stapling devices, hemostats, tissue sealants, ligating clips, and wound closure strips. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment’s pipeline products and gives details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
    View Document
  • Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons’ Confidence and Proficiency to Drive TAVR Procedure Volumes
    Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons’ Confidence and Proficiency to Drive TAVR Procedure Volumes

    $3,500.00

    $3,500.00

    From:GBI Research

    Document Overview:
    GBI Research’s “Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons’ Confidence and Proficiency to Drive TAVR Procedure Volumes” report examines the market, competitive landscape, and trends for the Transcatheter Heart Valves (THVs) market. The report provides comprehensive information on the key trends affecting these segments, and key analytical content related to market dynamics. The report also reviews the competitive landscape and provides a detailed analysis of the pipeline products for each segment, as well as details of important Mergers and Acquisitions (M&A) deals. The report has been compiled using data and information sourced from proprietary databases, primary and secondary research and in-house analysis carried out by GBI Research’s team of industry experts.
    View Document
  • Advanced Wound Management Market to 2019 - Increasing Incidence of Diabetes Leading to Chronic Wounds in Emerging Countries will Drive Future Growth
    Advanced Wound Management Market to 2019 - Increasing Incidence of Diabetes Leading to Chronic Wounds in Emerging Countries will Drive Future Growth

    $3,500.00

    $3,500.00

    From:GBI Research

    Document Overview:
    GBI Research’s report “Advanced Wound Management Market to 2019 - Increasing Incidence of Diabetes Leading to Chronic Wounds in Emerging Countries will Drive Future Growth” looks at the market, competitive landscape, and trends for eight advanced wound dressing segments: foams, hydrocolloids, hydrogels, semi-permeable films, hydrofibers, wound contact layers, alginates, and collagens. The report provides comprehensive information on the key trends affecting these segments and analyzes the market dynamics. It also reviews the competitive landscape and gives detailed analysis of each segment’s pipeline products, as well as details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts.
    View Document
  • Patient Monitoring Devices Market to 2019 - Increasing Investment in Healthcare Infrastructure in Emerging Economies Provides Significant Opportunity for Future Growth
    Patient Monitoring Devices Market to 2019 - Increasing Investment in Healthcare Infrastructure in Emerging Economies Provides Significant Opportunity for Future Growth

    $3,500.00

    $3,500.00

    From:GBI Research

    Document Overview:
    GBI Research’s report “Patient Monitoring Devices Market to 2019 - Increasing Investment in Healthcare Infrastructure in Emerging Economies Provides Significant Opportunity for Future Growth” looks at the market, competitive landscape, and trends for the seven patient monitoring devices market categories: remote patient monitoring devices, micro-electro mechanical systems, patient monitoring accessories, non-invasive blood pressure monitors, multiparameter patient monitoring devices, neonatal monitors and fetal monitors. The report provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape and gives a detailed analysis of each segment’s pipeline products, as well as details of important M&A (Mergers and Acquisitions) deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
    View Document
Per Page: 152550